Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

CHMP adopts positive opinion on Avastin/Xeloda combination in metastatic breast cancer

April 18, 2011

FDA approves Sylatron for injection as adjuvant treatment for melanoma

April 12, 2011

Bradmer Pharma ends Neuradiab license agreement for glioblastoma multiforme

April 8, 2011

New DC-based cancer vaccine uses Fab fragment of milatuzumab to present CEA

April 7, 2011

Bellicum granted award to support CaspaCIDe cancer therapy

March 31, 2011

Immune surrogate response predicts clinical efficacy for TroVax

March 30, 2011

BMS' ipilimumab approved in U.S. for unresectable or metastatic melanoma

March 28, 2011

Genesis Biopharma develops active immunotherapy platform for cancer

March 25, 2011

KaloBios begins phase I trial of anti-EphA3 monoclonal antibody in hematologic malignancies

March 24, 2011

OncoTherapy Science initiates gastric cancer vaccine trial in Singapore

March 24, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...